ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Eggermont and company answer some key questions at ESMO 2014 about the Cancer Core Europe initiative, which looks to collate data and research from six key European cancer centres to create a fully integrated and collaborative 'e-hospital'.
Prof Alexander Eggermont - Gustave Roussy, Villejuif, France
Prof Carlos Caldas - Cancer Research UK Cambridge Institute, Cambridge, UK
Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Prof Jan Schellens - Netherlands Cancer Institute, Amsterdam, Netherlands
Prof Alejandro Piris - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Prof Thorston Zenz - National Center for Tumor Diseases, Heidelberg, Germany
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Systemic anti-cancer performance matrix